Published in Eur Urol on August 01, 2000
Laparoscopic partial nephrectomy: Newer trends. Indian J Urol (2009) 0.83
Complications of laparoscopic partial nephrectomy. World J Urol (2008) 0.82
Laparoscopic total and partial nephrectomy-the new standard? Rev Urol (2003) 0.81
Laparoscopic radical nephrectomy: morcellate or leave intact? Definitely morcellate! Rev Urol (2002) 0.77
Zero ischaemia laparoscopic nephron-sparing surgery by re-suturing. Contemp Oncol (Pozn) (2014) 0.75
Intraoperative laparoscopic complications for urological cancer procedures. World J Clin Cases (2015) 0.75
Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res (1994) 3.43
Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N Engl J Med (1998) 3.14
The efficacy of dihydrotestosterone transdermal gel before primary hypospadias surgery: a prospective, controlled, randomized study. J Urol (2007) 2.85
Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med (1993) 2.85
Dosimetric effects of needle divergence in prostate seed implant using 125I and 103Pd radioactive seeds. Med Phys (2000) 2.67
Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system. Br J Cancer (1999) 2.34
Detection of prostate cancer with a microbubble ultrasound contrast agent. Lancet (2001) 2.23
Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production. J Exp Med (1997) 2.14
Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue. J Pathol (2000) 2.11
Evaluation and management of renal injuries: consensus statement of the renal trauma subcommittee. BJU Int (2004) 2.09
Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor. Cancer Res (1998) 2.07
Urinary incontinence in the elderly and age-dependent apoptosis of rhabdosphincter cells. Lancet (1999) 1.92
Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone. Mol Endocrinol (1993) 1.73
Androgen receptors in prostate cancer. Endocr Relat Cancer (2002) 1.71
New onset hypertension after extracorporeal shock wave lithotripsy: age related incidence and prediction by intrarenal resistive index. J Urol (1997) 1.70
Distant metastases from prostatic carcinoma express androgen receptor protein. Cancer Res (1995) 1.63
Neobladder emptying failure in males: incidence, etiology and therapeutic options. J Urol (2006) 1.61
Urethra-sparing cystectomy and orthotopic urinary diversion in women with malignant pelvic tumors. Cancer (2001) 1.58
Testicular torsion: late results with special regard to fertility and endocrine function. J Urol (1980) 1.52
Metastatic lesions from prostate cancer do not express oestrogen and progesterone receptors. J Pathol (1997) 1.52
Sildenafil modulates hemodynamics and pulmonary gas exchange. Am J Respir Crit Care Med (2001) 1.50
Laparoscopic surgery for pheochromocytoma: adrenalectomy, partial resection, excision of paragangliomas. J Urol (1998) 1.47
Genes differentially expressed in prostate cancer. BJU Int (2004) 1.45
Zoledronic acid influences growth, migration and invasive activity of prostate cancer cells in vitro. Prostate Cancer Prostatic Dis (2012) 1.43
Regulation of prostatic growth and function by peptide growth factors. Prostate (1996) 1.42
Lich-Gregoir reimplantation causes less discomfort than Politano-Leadbetter technique: Results of a prospective, randomized, pain scale-oriented study in a pediatric population. Eur Urol (2005) 1.39
Laparoscopic pyeloplasty. Urol Clin North Am (2000) 1.36
Extracorporeal shock wave lithotripsy versus ureteroscopy for distal ureteral calculi: a prospective randomized study. J Urol (1999) 1.33
Spontaneous remission of urinary tract obstruction and ascites in a fetus with posterior urethral valves. Ultrasound Obstet Gynecol (1991) 1.27
Androgen receptor--an update of mechanisms of action in prostate cancer. Urol Res (2000) 1.25
Age, prostate-specific antigen, and digital rectal examination as determinants of the probability of having prostate cancer. Urology (2001) 1.24
The female urethral sphincter: a morphological and topographical study. J Urol (1998) 1.24
Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous testicular carcinoma: long-term outcome. J Urol (2000) 1.24
Radical prostatectomy: the value of preoperative, individually labeled apical biopsies. J Urol (2000) 1.23
Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotides. Cancer Gene Ther (2000) 1.21
Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells. J Urol (1999) 1.20
Treatment of giant ancient pelvic schwannoma. Tech Urol (2001) 1.20
Expression, structure, and function of androgen receptor in advanced prostatic carcinoma. Prostate (1998) 1.19
Posttraumatic posterior urethral stricture repair: anatomy, surgical approach and long-term results. J Urol (1997) 1.19
Bacillus Calmette-Guérin mycobacteria stimulate human blood dendritic cells. Int J Cancer (1997) 1.19
Guidelines for the diagnosis and treatment of benign prostatic hyperplasia: a comparative, international overview. Urology (2001) 1.18
Laparoscopic nephron sparing surgery for small renal cell carcinoma. J Urol (1998) 1.17
Androgen receptor status of lymph node metastases from prostate cancer. Prostate (1996) 1.16
Crossing vessels at the ureteropelvic junction: detection with contrast-enhanced color Doppler imaging. Radiology (1999) 1.16
Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype. Clin Cancer Res (2001) 1.13
Transurethral prostatectomy: mortality and morbidity. Prostate (1996) 1.13
Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer. Prostate (2000) 1.12
Association of SRD5A2 genotype and pathological characteristics of prostate tumors. Cancer Res (2000) 1.11
Isolated right-sided varicocele as a salvage pathway for portal hypertension. Int J Clin Pract (2005) 1.08
Light microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia. J Urol (1979) 1.08
Primary lymphatic metastatic spread in testicular cancer occurs ventral to the lumbar vessels. Urology (2002) 1.07
Morphometry in experimental pathology: methods, baseline data and applications. Int Rev Exp Pathol (1976) 1.07
Comparison of contrast enhanced color Doppler targeted biopsy to conventional systematic biopsy: impact on Gleason score. J Urol (2007) 1.07
Laparoscopic partial adrenalectomy in patients with aldosterone-producing adenomas: indications, technique, and results. Urology (2003) 1.06
Transforming growth factors-beta 1 and beta 2 in serum and urine from patients with bladder carcinoma. J Urol (1996) 1.05
Orgotein: a new antiinflammatory metalloprotein drug evaluation of clinical efficacy and safety in inflammatory conditions of the urinary tract. Int Urol Nephrol (1974) 1.04
Laparoscopic partial cystectomy for leiomyoma of the bladder wall. J Urol (2002) 1.03
Laboratory survey of drug-resistant Streptococcus pneumoniae in New York City, 1993-1995. Emerg Infect Dis (1998) 1.02
Mechanisms of endocrine therapy-responsive and -unresponsive prostate tumours. Endocr Relat Cancer (2005) 1.02
Age dependent apoptosis and loss of rhabdosphincter cells. J Urol (2000) 1.01
DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reaction. Prostate (1993) 1.01
Molecular biology of the androgen receptor: from molecular understanding to the clinic. Eur Urol (2001) 1.01
Laparoscopic partial nephrectomy. The European experience. Urol Clin North Am (2000) 1.01
Androgen signal transduction and prostatic carcinoma. World J Urol (1994) 1.00
Management of benign prostatic hyperplasia with particular emphasis on aromatase inhibitors. J Steroid Biochem Mol Biol (1993) 1.00
Quality of life after cystectomy and orthotopic neobladder versus ileal conduit urinary diversion. World J Urol (2000) 1.00
Upgrading of Gleason score 6 prostate cancers on biopsy after prostatectomy in the low and intermediate tPSA range. Prostate Cancer Prostatic Dis (2009) 0.99
Changing diagnostic and therapeutic concepts in high-flow priapism. Int J Impot Res (2005) 0.99
The effect of radiation on the fracture repair process. A biomechanical evaluation of a closed fracture in a rat model. J Orthop Res (1989) 0.98
Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor and epidermal growth factor. Eur Urol (1995) 0.98
Laparoscopic and retroperitoneoscopic repair of ureteropelvic junction obstruction. Urology (1996) 0.98
Anatomic and functional studies of the male and female urethral sphincter. World J Urol (2000) 0.97
Mediators of the long-term impact of child sexual abuse: perceived stigma, betrayal, powerlessness, and self-blame. Child Abuse Negl (1996) 0.97
Point mutation in the DNA binding domain of the androgen receptor in two families with Reifenstein syndrome. Am J Hum Genet (1992) 0.96
Improved method for the rapid determination of isosorbide dinitrate in human plasma and its application in pharmacokinetic studies. J Chromatogr (1978) 0.96
Measurement of serum prostate-specific membrane antigen, a new prognostic marker for prostate cancer. Urology (1998) 0.96
Human renal-cell carcinoma tissue contains dendritic cells. Int J Cancer (1996) 0.96
Rationale and technique of nerve sparing radical cystectomy before an orthotopic neobladder procedure in women. J Urol (1995) 0.95
Influence of exposure to moderate altitude on the plasma concentraton of cortisol, aldosterone, renin, testosterone, and gonadotropins. Eur J Appl Physiol Occup Physiol (1980) 0.95
Retracted Transurethral ultrasonography-guided injection of adult autologous stem cells versus transurethral endoscopic injection of collagen in treatment of urinary incontinence. World J Urol (2007) 0.95
Laparoscopic heminephroureterectomy in pediatric patients. J Urol (1997) 0.94
Basic fibroblast growth factor levels in cancer cells and in sera of patients suffering from proliferative disorders of the prostate. Prostate (1997) 0.94
Prospective randomized trial using laser acupuncture versus desmopressin in the treatment of nocturnal enuresis. Eur Urol (2001) 0.94
Left-sided laparoscopic adrenalectomy. Scand J Urol Nephrol (1993) 0.93
Mutant androgen receptors in prostatic tumors distinguish between amino-acid-sequence requirements for transactivation and ligand binding. Int J Cancer (1995) 0.93
Frequency and clinical significance of transition zone cancer in prostate cancer screening. Prostate (1997) 0.93
Dosimetric effects of edema in permanent prostate seed implants: a rigorous solution. Int J Radiat Oncol Biol Phys (2000) 0.92
Expression of transforming growth factors beta-1, beta 2 and beta 3 in human bladder carcinomas. Br J Cancer (1997) 0.92
Anatomy and innervation of the rhabdosphincter of the male urethra. Prostate (1996) 0.92